Oramed Pharmaceuticals
ORMP
#8839
Rank
S$0.12 B
Marketcap
$3.15
Share price
1.30%
Change (1 day)
8.24%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - P/B ratio

P/B ratio as of November 2024 : 0.5355

According to Oramed Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Oramed Pharmaceuticals - P/B ratio (from 2008 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-310.5721-81.62%
2022-12-313.11-2.49%
2021-12-313.19-10.79%
2020-12-313.58-31.48%
2019-12-315.22189.06%
2018-12-311.81-68.1%
2017-12-315.6667.26%
2016-12-313.39-23.08%
2015-12-314.40111.52%
2014-12-312.08-87.61%
2013-12-3116.8267.54%
2012-12-314.57-22.81%
2011-12-315.92-72.67%
2010-12-3121.7102.66%
2009-12-3110.777.63%
2008-12-316.02
2007-12-31N/A
2006-12-31N/A
2005-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
10.1 1,783.91%๐Ÿ‡บ๐Ÿ‡ธ USA
25.1 4,589.33%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
1.55 188.87%๐Ÿ‡ซ๐Ÿ‡ท France
2.18 306.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
1.30 142.87%๐Ÿ‡บ๐Ÿ‡ธ USA